Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA
- 9 August 2005
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 65 (3), 366-370
- https://doi.org/10.1212/01.wnl.0000171704.50395.ba
Abstract
Objective: To determine whether pretreatment markers of coagulation and fibrinolysis are related to recanalization and functional outcome.Keywords
This publication has 27 references indexed in Scilit:
- Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen ActivatorStroke, 2004
- Effect of Incomplete (Spontaneous and Postthrombolytic) Recanalization After Middle Cerebral Artery OcclusionStroke, 2004
- Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activatorThrombosis and Haemostasis, 2004
- Is the Benefit of Early Recanalization Sustained at 3 Months?Stroke, 2003
- Thrombolysis for acute strokeCurrent Opinion in Neurology, 2003
- Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeAnnals of Neurology, 2001
- Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemiaAnnals of Neurology, 2001
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke?Stroke, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993